SNCA and multiple system atrophy: New insights from ongoing genetic initiatives in people with Parkinson’s disease and multiple system atrophy, as well as future clinical and molecular genetic studies of the present family have the potential to unravel the involvement of novel genes associated with the development of α-synuclein pathology.